+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Dificid"

Antibiotics Market Report by Action Mechanism, Drug Class, Spectrum of Activity, Route of Administration, End User, and Region 2024-2032 - Product Thumbnail Image

Antibiotics Market Report by Action Mechanism, Drug Class, Spectrum of Activity, Route of Administration, End User, and Region 2024-2032

  • Report
  • August 2024
  • 137 Pages
  • Global
From
DIFICID Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

DIFICID Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
Macrolide Antibiotics Market By Drug Type, By Route of Administration, By Indication, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2023-2032 - Product Thumbnail Image

Macrolide Antibiotics Market By Drug Type, By Route of Administration, By Indication, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2023-2032

  • Report
  • October 2023
  • 306 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Dificid is an antibiotic used to treat Clostridioides difficile (C. difficile) infection, a type of bacterial infection that can cause severe diarrhea and other symptoms. It is a macrolide antibiotic, which works by inhibiting the growth of C. difficile bacteria. Dificid is approved for use in adults and children over the age of two months. It is available in tablet and oral suspension forms. The Dificid market is composed of pharmaceutical companies that manufacture and distribute the drug. These companies are responsible for the research and development of the drug, as well as its marketing and sales. The market is highly competitive, with several companies offering similar products. Some of the companies in the Dificid market include Merck & Co., Inc., Pfizer, Inc., GlaxoSmithKline plc, and AstraZeneca plc. Show Less Read more